Avant Brands (AVNT) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
15 Oct, 2026Executive summary
Q3 2026 returned to net income of $0.2 million from a $1.9 million net loss in Q3 2025; Adjusted EBITDA rose to $1.3 million from $0.2 million.
Recreational revenue grew 51% to $4.1 million, more than half of Q3 net revenue, while wholesale revenue declined in both export and domestic channels.
Financial highlights
Q3 gross revenue was $9.0 million (-16% YoY) and net revenue was $7.3 million (-22%); gross profit rose to $2.5 million from $1.7 million.
Q3 net income was $0.2 million versus a $1.9 million net loss; Adjusted EBITDA was $1.3 million versus $0.2 million, reflecting sales mix, stronger gross margins and lower operating expenses.
9M gross revenue was $26.6 million (-12% YoY), net revenue $22.2 million (-16%) and gross profit $2.8 million versus $3.1 million.
9M Adjusted EBITDA was negative $0.6 million versus positive $3.2 million, primarily due to lower net revenue and gross profit.
Outlook and guidance
Management expects further Flowr retrofit benefits, including lower energy and HVAC costs and improved cultivation performance as post-retrofit crop cycles progress; Q3 harvest growth is an early result, not the full run-rate.
Measurement and verification remains necessary for up to $2.0 million of incentive funding; EU-GMP certification depends on remediation and auditor review and is not assured.
Priorities include Canadian branded recreational execution through BLK MKT and Tenzo, international medical export capability if EU-GMP certification is obtained, and disciplined capital allocation.
Latest events from Avant Brands
- Premium cannabis producer with strong sales growth, global reach, and award-winning brands.AVNT
Investor presentation - $41.3M F2025 sales, 34% YTD recreational growth, and $1.7M YTD net cash flow from operations.AVNT
Q2 2026 - Sixth consecutive positive Adjusted EBITDA and 11% export revenue growth highlight Q2 2025.AVNT
Q2 2025 - Premium cannabis producer with strong sales, innovation, and rapid export growth.AVNT
Investor presentation - Recreational sales surged 37% while export declines and upgrades weighed on Q1 profit.AVNT
Q1 2026 - Premium cannabis producer with strong export markets and certified indoor facilities.AVNT
Investor presentation - Gross sales hit $41.3M, recreational revenue up 19%, and net loss down 56% in F2025.AVNT
Q4 2025 - Revenue and cash flow rose sharply, with domestic wholesale up 307% and EBITDA positive again.AVNT
Q3 2025 - Record Q3 revenue and export growth highlight Avant's accelerating global cannabis expansion.AVNT
Q3 2024